Skip to content

Zymeworks ZYME Intangible assets — net

Intangible assets — net at other companies

Pfizer logo
PfizerPFE
Amgen logo
AmgenAMGN
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
Charles River Laboratories logo
Charles River LaboratoriesCRL
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.79B+125%

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's intangible assets — net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's intangible assets — net?
Zymeworks (ZYME) reported intangible assets — net of $1.17M in Q1 2026.
How has Zymeworks's intangible assets — net changed year-over-year?
Zymeworks's intangible assets — net decreased by 65.1% year-over-year, from $3.36M to $1.17M.
What is the long-term trend for Zymeworks's intangible assets — net?
Over 4 years (2021 to 2025), Zymeworks's intangible assets — net has grown at a -23.0% compound annual growth rate (CAGR), from $3.84M to $1.35M.